Genes associated with Alzheimer's disease: an overview and current status

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · see citing works

Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease

Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786 · see citing works

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works

Alzheimer’s disease

Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134 · see citing works

<i>TREM2</i> Variants in Alzheimer's Disease

Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · see citing works

Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease

Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · see citing works

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234 · see citing works

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · see citing works

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · see citing works

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849 · see citing works

Role of Genes and Environments for Explaining Alzheimer Disease

Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798 · see citing works

Alzheimer Mechanisms and Therapeutic Strategies

Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · see citing works

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., et al. (2012) · Nature · doi:10.1038/nature11283 · Cited by 1,738 · see citing works

The role of apolipoprotein E in Alzheimer's disease

Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513 · see citing works

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works

Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease

Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219 · see citing works

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., et al. (2001) · Nature Neuroscience · doi:10.1038/nn0901-887 · Cited by 1,209 · see citing works

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168 · see citing works

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · see citing works

Amyloid Precursor Protein Trafficking, Processing, and Function

Thinakaran, G., & Koo, E. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800019200 · Cited by 1,141 · see citing works

Review Article: Genetics of Alzheimer Disease

Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029 · see citing works

Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta

Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004 · see citing works

Apolipoprotein E in Alzheimer’s disease and other neurological disorders

Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · see citing works

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J. S., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J. E., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 779 · see citing works

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

Hendriks, L., van Duijn, C. M., Cras, P. P., Cruts, M., Hul, W. V., van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., Martin, J., et al. (1992) · Nature Genetics · doi:10.1038/ng0692-218 · Cited by 735 · see citing works

The genetics of Alzheimer disease

Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727 · see citing works

APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE

Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707 · see citing works

Mutations in Two Genes Encoding Different Subunits of a Receptor Signaling Complex Result in an Identical Disease Phenotype

Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683 · see citing works

Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein

Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655 · see citing works

Proteolytic processing and cell biological functions of the amyloid precursor protein

Strooper, B. D., & Annaert, W. G. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1857 · Cited by 628 · see citing works

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

Lang, H., Jacobsen, H. J., Ikemizu, S., Andersson, C., Harlos, K., Madsen, L. S., Hjorth, P., Søndergaard, L., Svejgaard, A., Wucherpfennig, K. W., et al. (2002) · Nature Immunology · doi:10.1038/ni835 · Cited by 592 · see citing works

Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS

Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800069-jlr200 · Cited by 580 · see citing works

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

Initiative, T. A. D. N., Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L. L., Imboywa, S., Lee, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3435 · Cited by 570 · see citing works

Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades Later

Solomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000231980 · Cited by 557 · see citing works

Isoform-specific binding of apolipoprotein E to beta-amyloid.

LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540 · see citing works

Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease

Morris, G. P., Clark, I. A., & Vissel, B. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0135-5 · Cited by 522 · see citing works

Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE

Bertram, L., Lange, C., Mullin, K., Parkinson, M., Hsiao, M., Hogan, M. F., Schjeide, B. M. M., Hooli, B., DiVito, J., Ionita, I., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.10.008 · Cited by 511 · see citing works

A Genome-Wide Association Study Identifies Novel Alleles Associated with Hair Color and Skin Pigmentation

Han, J., Kraft, P., Nan, H., Guo, Q., Chen, C., Qureshi, A., Hankinson, S. E., Hu, F. B., Duffy, D. L., Zhao, Z. Z., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000074 · Cited by 499 · see citing works

A Portrait of Alzheimer Secretases--New Features and Familiar Faces

Esler, W. P., & Wolfe, M. S. (2001) · Science · doi:10.1126/science.1064638 · Cited by 493 · see citing works

Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein

Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinistö, L., Halonen, P., & Kontula, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331902 · Cited by 493 · see citing works

Clusterin

Jones, S. (2002) · The International Journal of Biochemistry &amp; Cell Biology · doi:10.1016/s1357-2725(01)00155-8 · Cited by 488 · see citing works

Alzheimer’s Disease Genetics: From the Bench to the Clinic

Karch, C. M., Cruchaga, C., & Goate, A. M. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.041 · Cited by 473 · see citing works

What makes a good genetic association study?

Hattersley, A. T., & McCarthy, M. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67531-9 · Cited by 465 · see citing works

Locus‐specific mutation databases for neurodegenerative brain diseases

Cruts, M., Theuns, J., & Broeckhoven, C. V. (2012) · Human Mutation · doi:10.1002/humu.22117 · Cited by 462 · see citing works

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease

Cruchaga, C., Karch, C. M., Jin, S. C., Benitez, B. A., Cai, Y., Guerreiro, R., Harari, O., Norton, J., Budde, J., Bertelsen, S., et al. (2014) · Nature · doi:10.1038/nature12825 · Cited by 461 · see citing works

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts

Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B. H., Phillips, J. H., Pekkarinen, P., et al. (2000) · Nature Genetics · doi:10.1038/77153 · Cited by 460 · see citing works

Increased Steady-State Levels of CUGBP1 in Myotonic Dystrophy 1 Are Due to PKC-Mediated Hyperphosphorylation

Kuyumcu-Martinez, N. M., Wang, G., & Cooper, T. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.027 · Cited by 445 · see citing works

Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ϵ4, and the Risk of Late-Onset Alzheimer Disease in African Americans

Reitz, C., Jun, G., Naj, A., Rajbhandary, R., Vardarajan, B. N., Wang, L.-S., Valladares, O., Lin, C.-F., Larson, E. B., Graff-Radford, N. R., et al. (2013) · JAMA · doi:10.1001/jama.2013.2973 · Cited by 431 · see citing works

Clusterin: Physiologic and pathophysiologic considerations

Rosenberg, M. E., & Silkensen, J. R. (1995) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(95)00027-m · Cited by 427 · see citing works

Molecular mapping of alzheimer‐type dementia in Down's syndrome

Prasher, V. P., Farrer, M. J., Kessling, A. M., Fisher, E. M. C., West, R. J., Barber, P. C., & Butler, A. C. (1998) · Annals of Neurology · doi:10.1002/ana.410430316 · Cited by 414 · see citing works

Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms

Bentahir, M., Nyabi, O., Verhamme, J., Tolia, A., Horré, K., Wiltfang, J., Esselmann, H., & Strooper, B. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03578.x · Cited by 412 · see citing works

Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance

Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4025 · Cited by 410 · see citing works

Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology

GERAD consortium, Chapuis, J., Hansmannel, F., Gistelinck, M., Mounier, A., Van Cauwenberghe, C., Kolen, K. V., Geller, F., Sottejeau, Y., Harold, D., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.1 · Cited by 407 · see citing works

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease

Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404 · see citing works

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

Cruchaga, C., Kauwe, J. S. K., Harari, O., Jin, S. C., Cai, Y., Karch, C. M., Benitez, B. A., Jeng, A. T., Skorupa, T., Carrell, D., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.026 · Cited by 383 · see citing works

Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E. S., Chung, C. Y., Baru, V., Shulman, J. M., Parrado, A., Bevis, B. J., Valastyan, J. S., et al. (2011) · Science · doi:10.1126/science.1213210 · Cited by 379 · see citing works

Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease

Potkin, S. G., Guffanti, G., Lakatos, A., Turner, J. A., Kruggel, F., Fallon, J. H., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006501 · Cited by 376 · see citing works

Using Exome Sequencing to Reveal Mutations in TREM2 Presenting as a Frontotemporal Dementia–like Syndrome Without Bone Involvement

Guerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374 · see citing works

Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias

Beecham, G. W., Hamilton, K., Naj, A. C., Martin, E. R., Huentelman, M., Myers, A. J., Corneveaux, J. J., Hardy, J., Vonsattel, J.-P., Younkin, S. G., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004606 · Cited by 343 · see citing works

Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains

Karch, C. M., Jeng, A. T., Nowotny, P., Cady, J., Cruchaga, C., & Goate, A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050976 · Cited by 328 · see citing works

Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease

DemGene, Steinberg, S., Stefansson, H., Jonsson, T., Johannsdottir, H., Ingason, A., Helgason, H., Sulem, P., Magnusson, O. T., Gudjonsson, S. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3246 · Cited by 324 · see citing works

<scp>F</scp>yn inhibition rescues established memory and synapse loss in <scp>A</scp>lzheimer mice

Kaufman, A. C., Salazar, S. V., Haas, L. T., Yang, J., Kostylev, M. A., Jeng, A. T., Robinson, S. A., Gunther, E. C., van Dyck, C. H., Nygaard, H. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24394 · Cited by 314 · see citing works

Coding variants in TREM2 increase risk for Alzheimer's disease

Jin, S. C., Benitez, B. A., Karch, C. M., Cooper, B., Skorupa, T., Carrell, D., Norton, J. B., Hsu, S., Harari, O., Cai, Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu277 · Cited by 314 · see citing works

Role of complement in neurodegeneration and neuroinflammation

Bonifati, D. M., & Kishore, U. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.03.007 · Cited by 310 · see citing works

Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport

Pigino, G. F., Morfini, G. A., Pelsman, A., Mattson, M. P., Brady, S. T., & Busciglio, J. A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04499.2003 · Cited by 300 · see citing works

Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age

Kok, E., Haikonen, S., Luoto, T., Huhtala, H., Goebeler, S., Haapasalo, H., & Karhunen, P. J. (2009) · Annals of Neurology · doi:10.1002/ana.21696 · Cited by 299 · see citing works

Association of Brain DNA Methylation in<i>SORL1</i>,<i>ABCA7</i>,<i>HLA-DRB5</i>,<i>SLC24A4</i>, and<i>BIN1</i>With Pathological Diagnosis of Alzheimer Disease

Yu, L., Chibnik, L. B., Srivastava, G. P., Pochet, N., Yang, J., Xu, J., Kozubek, J., Obholzer, N., Leurgans, S. E., Schneider, J. A., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3049 · Cited by 290 · see citing works

The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE

Guerreiro, R. J., Gustafson, D. R., & Hardy, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.025 · Cited by 285 · see citing works

PICALM modulates autophagy activity and tau accumulation

Moreau, K., Fleming, A., Imarisio, S., Lopez Ramirez, A., Mercer, J. L., Jimenez-Sanchez, M., Bento, C. F., Puri, C., Zavodszky, E., Siddiqi, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms5998 · Cited by 281 · see citing works

The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments

Offe, K., Dodson, S. E., Shoemaker, J. T., Fritz, J. J., Gearing, M., Levey, A. I., & Lah, J. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4946-05.2006 · Cited by 279 · see citing works

Human<i>APOE</i>Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice

Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., Hansen, J. C., Sullivan, P. M., & Paul, S. M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0887-09.2009 · Cited by 274 · see citing works

Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.

Kamino, K., Orr, H. T., Payami, H., Wijsman, E. M., Alonso, M. E., Pulst, S. M., Anderson, L., O'dahl, S., Nemens, E. J., & White, J. A. (1992) · PubMed · Cited by 268 · see citing works

Clusterin: A forgotten player in Alzheimer's disease

Nuutinen, T., Suuronen, T., Kauppinen, A., & Salminen, A. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.007 · Cited by 267 · see citing works

<i>TREM2</i>Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis

Cady, J., Koval, E. D., Benitez, B. A., Zaidman, C., Jockel-Balsarotti, J., Allred, P., Baloh, R. H., Ravits, J., Simpson, E., Appel, S. H., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6237 · Cited by 262 · see citing works

Genomic organization of the human amyloid beta-protein precursor gene

Yoshikai, S.-I., Sasaki, H., Doh‐ura, K., Furuya, H., & Sakaki, Y. (1990) · Gene · doi:10.1016/0378-1119(90)90310-n · Cited by 259 · see citing works

TREM2and Neurodegenerative Disease

Reitz, C., & Mayeux, R. P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1306509 · Cited by 254 · see citing works

Retromer Binds the FANSHY Sorting Motif in SorLA to Regulate Amyloid Precursor Protein Sorting and Processing

Fjorback, A. W., Seaman, M. N. J., Gustafsen, C., Mehmedbašić, A., Gokool, S., Wu, C., Militz, D., Schmidt, V., Madsen, P., Nyengaard, J. R., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2272-11.2012 · Cited by 253 · see citing works

Alzheimer’s disease phenotypes and genotypes associated with mutations in presenilin 2

Jayadev, S., Leverenz, J. B., Steinbart, E. J., Stahl, J. H., Klunk, W. E., Yu, C.-E., & Bird, T. D. (2010) · Brain · doi:10.1093/brain/awq033 · Cited by 246 · see citing works

Genome-wide association study of Alzheimer's disease

Kamboh, M. I., Demirci, F. Y., Wang, X., Minster, R. L., Carrasquillo, M. M., Pankratz, V. S., Younkin, S. G., Saykin, A. J., Initiative, A. D. N., Jun, G., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.45 · Cited by 242 · see citing works

Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate α-secretase activity

Kim, M., Suh, J., Romano, D., Truong, M. H., Mullin, K., Hooli, B., Norton, D., Tesco, G., Elliott, K., Wagner, S. L., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp323 · Cited by 234 · see citing works

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites

Brouwers, N., Van Cauwenberghe, C., Engelborghs, S., Lambert, J.-C., Bettens, K., Le Bastard, N., Pasquier, F., Montoya, A. G., Peeters, K., Mattheijssens, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.24 · Cited by 227 · see citing works

Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability

De Jonghe, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1665 · Cited by 223 · see citing works

Genetic Variation and Neuroimaging Measures in Alzheimer Disease

Biffi, A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.108 · Cited by 222 · see citing works

Plasma clusterin and the risk of Alzheimer disease

Schrijvers, E. M. C. (2011) · JAMA · doi:10.1001/jama.2011.381 · Cited by 220 · see citing works

AMPH-1/Amphiphysin/Bin1 functions with RME-1/Ehd1 in endocytic recycling

Pant, S., Sharma, M., Patel, K., Caplan, S., Carr, C. M., & Grant, B. D. (2009) · Nature Cell Biology · doi:10.1038/ncb1986 · Cited by 218 · see citing works

ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function

Suh, J., Choi, S. H., Romano, D. M., Gannon, M. A., Lesinski, A. N., Kim, D. Y., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.08.035 · Cited by 217 · see citing works

Complement Receptor 1: Disease associations and therapeutic implications

Khera, R., & Das, N. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.026 · Cited by 213 · see citing works

Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?

Mullane, K., & Williams, M. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.11.014 · Cited by 212 · see citing works

Deletion ofAbca7Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease

Kim, W. S., Li, H., Ruberu, K. R., Chan, S. L., Elliott, D. A., Low, J. K., Cheng, D., Karl, T., & Garner, B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4165-12.2013 · Cited by 209 · see citing works

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

Ramanan, V. K., Risacher, S. L., Nho, K. T., Kim, S., Swaminathan, S., Shen, L., Foroud, T., Hakonarson, H. H., Huentelman, M. J., Aisen, P. S. S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.19 · Cited by 202 · see citing works

Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein

Maloney, J. A., Bainbridge, T. W., Gustafson, A. E., Zhang, S., Kyauk, R. V., Steiner, P., van der Brug, M., Liu, Y., Ernst, J. A., Watts, R. J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589069 · Cited by 199 · see citing works

A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia

Duriez, B., Duquesnoy, P., Escudier, E. F., Bridoux, A.-M., Escalier, D., Rayet, I., Marcos, É., Vojtek, A.-M., Bercher, J., & Amselem, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611405104 · Cited by 198 · see citing works

Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred

Pastor, P., Roe, C. M., Villegas, A., Bedoya, G., Chakraverty, S., García, G., Tirado, V., Norton, J., Ríos, S., Martínez, M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10636 · Cited by 194 · see citing works

RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway

Kajiho, H., Saito, K., Tsujita, K., Kontani, K., Araki, Y., Kurosu, H., & Katada, T. (2003) · Journal of Cell Science · doi:10.1242/jcs.00718 · Cited by 191 · see citing works

Synapse development and plasticity: roles of ephrin/Eph receptor signaling

Lai, K., & Ip, N. Y. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.04.009 · Cited by 191 · see citing works

Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease

Tan, M., Yu, J., & Tan, L. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.06.004 · Cited by 187 · see citing works

Variant <i>TREM2</i> as Risk Factor for Alzheimer's Disease

Neumann, H., & Daly, M. J. (2013) · New England Journal of Medicine · doi:10.1056/nejme1213157 · Cited by 177 · see citing works

Apolipoprotein E and Alzheimer's Disease A Role in Amyloid Catabolism

Poirier, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05564.x · Cited by 171 · see citing works

Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms

Shulman, J. M., Imboywa, S., Giagtzoglou, N., Powers, M. P., Hu, Y., Devenport, D., Chipendo, P., Chibnik, L. B., Diamond, A., Perrimon, N., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt478 · Cited by 167 · see citing works

Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis

Xiao, Q., Gil, S.-C., Yan, P., Wang, Y., Han, S., Gonzales, E., Perez, R., Cirrito, J. R., & Lee, J.-M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338376 · Cited by 166 · see citing works

Clusterin (Apolipoprotein J) Protein Levels Are Increased in Hippocampus and in Frontal Cortex in Alzheimer's Disease

Lidström, A.-M., Bogdanović, N., Hesse, C., Volkmann, I., Davidsson, P., & Blennow, K. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6892 · Cited by 163 · see citing works

MEF2 Is an In Vivo Immune-Metabolic Switch

Clark, R. I., Tan, S. W. S., Péan, C. B., Roostalu, U., Vivancos, V., Bronda, K., Pilátová, M., Fu, J., Walker, D. W., Berdeaux, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.007 · Cited by 163 · see citing works

Meta-analysis of the Association Between Variants in SORL1 and Alzheimer Disease

Reitz, C. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.346 · Cited by 162 · see citing works

Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells

Kim, W., Guillemin, G., Glaros, E., Lim, C. K., & Garner, B. (2006) · NeuroReport · doi:10.1097/01.wnr.0000221833.41340.cd · Cited by 158 · see citing works

Genetic Susceptibility for Alzheimer Disease Neuritic Plaque Pathology

Shulman, J. M., Chen, K., Keenan, B. T., Chibnik, L. B., Fleisher, A., Thiyyagura, P., Roontiva, A., Aubin, C., Patsopoulos, N. A., Corneveaux, J. J., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2815 · Cited by 156 · see citing works

A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death

Alzheimer's Disease Genetics Consortium, Wetzel-Smith, M. K., Hunkapiller, J., Bhangale, T. R., Srinivasan, K., Maloney, J. A., Atwal, J. K., Sa, S. M., B Yaylaoglu, M., Foreman, O., et al. (2014) · Nature Medicine · doi:10.1038/nm.3736 · Cited by 153 · see citing works

LRP2 in ependymal cells regulates BMP signaling in the adult neurogenic niche

Gajera, C. R., Emich, H., Lioubinski, O., Christ, A., Beckervordersandforth, R., Yoshikawa, K., Bachmann, S., Christensen, E., Götz, M., Kempermann, G., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.065912 · Cited by 153 · see citing works

Incidence of cerebral microbleeds in preclinical Alzheimer disease

Yates, P. A., Desmond, P. M., Phal, P. M., Steward, C., Szoeke, C., Salvado, O., Ellis, K. A., Martins, R. N., Masters, C. L., Ames, D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000285 · Cited by 150 · see citing works

Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia

Chen, Z., Shojaee, S., Buchner, M., Geng, H., Lee, J. W., Klemm, L., Titz, B., Graeber, T. G., Park, E., Tan, Y. X., et al. (2015) · Nature · doi:10.1038/nature14231 · Cited by 149 · see citing works

Apolipoprotein E and Alzheimer Disease: An Update on Genetic and Functional Analyses

Saunders, A. M. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.9.751 · Cited by 148 · see citing works

Two rare <i>AKAP9</i> variants are associated with Alzheimer's disease in African Americans

Logue, M. W., Schu, M., Vardarajan, B. N., Farrell, J., Bennett, D. A., Buxbaum, J. D., Byrd, G. S., Ertekin‐Taner, N., Evans, D., Foroud, T., et al. (2014) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2014.06.010 · Cited by 136 · see citing works

ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro

Chan, S. L., Kim, W. S., Kwok, J. B., Hill, A. F., Cappai, R., Rye, K., & Garner, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05433.x · Cited by 133 · see citing works

Presenilins: Members of the γ-Secretase Quartets, But Part-Time Soloists Too

Wakabayashi, T., & Strooper, B. D. (2008) · Physiology · doi:10.1152/physiol.00009.2008 · Cited by 124 · see citing works

Distinct Endocytic Mechanisms of CD22 (Siglec-2) and Siglec-F Reflect Roles in Cell Signaling and Innate Immunity

Tateno, H., Li, H., Schur, M. J., Bovin, N. V., Crocker, P. R., Wakarchuk, W. W., & Paulson, J. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00383-07 · Cited by 123 · see citing works

Structural Insight into the Zinc Finger CW Domain as a Histone Modification Reader

He, F., Umehara, T., Saito, K., Harada, T., Watanabe, S., Yabuki, T., Kigawa, T., Takahashi, M., Kuwasako, K., Tsuda, K., et al. (2010) · Structure · doi:10.1016/j.str.2010.06.012 · Cited by 121 · see citing works

Distribution and Expression of Picalm in Alzheimer Disease

Baig, S., Joseph, S. A., Tayler, H., Abraham, R., Owen, M. J., Williams, J., Kehoe, P. G., & Love, S. (2010) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e3181f52e01 · Cited by 115 · see citing works

SnapShot: genetics of Alzheimer's disease.

Guerreiro, R., Bras, J., & Hardy, J. (2013) · Cell · doi:10.1016/j.cell.2013.10.037 · Cited by 114 · see citing works

APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease

Vélez, J. I., Lopera, F., Sepulveda-Falla, D., Patel, H. R., Johar, A. S., Chuah, A., Tobón, C., Rivera, D., Villegas, A., Cai, Y., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.177 · Cited by 111 · see citing works

EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility

Yamazaki, T., Masuda, J., Omori, T., Usui, R., Akiyama, H., & Maru, Y. (2008) · Journal of Cell Science · doi:10.1242/jcs.036467 · Cited by 107 · see citing works

Sortilin and SorLA Display Distinct Roles in Processing and Trafficking of Amyloid Precursor Protein

Gustafsen, C., Glerup, S., Pallesen, L. T., Olsen, D., Andersen, O. M., Nykjær, A., Madsen, P., & Petersen, C. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2371-12.2013 · Cited by 106 · see citing works

Genomic organization of the human-amyloid beta-protein precursor gene

Yoshikai, S.-I., Sasaki, H., Doh‐ura, K., Furuya, H., & Sakaki, Y. (1991) · Gene · doi:10.1016/0378-1119(91)90093-q · Cited by 105 · see citing works

Expression of desmosomal proteins in squamous cell carcinomas of the skin

Kurzen, H., Münzing, I., & Hartschuh, W. (2003) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2003.00122.x · Cited by 101 · see citing works

The Role of Clusterin, Complement Receptor 1, and Phosphatidylinositol Binding Clathrin Assembly Protein in Alzheimer Disease Risk and Cerebrospinal Fluid Biomarker Levels

Schjeide, B. M., Schnack, C., Lambert, J., Lill, C. M., Kirchheiner, J., Tumani, H., Otto, M., Tanzi, R. E., Lehrach, H. R., Amouyel, P., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.196 · Cited by 100 · see citing works

The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease

Antúnez, C., Boada, M., González‐Pérez, A., Gayán, J., Ramírez‐Lorca, R., Marín, J., Hernández, I., Moreno‐Rey, C., Morón, F. J., López‐Arrieta, J., et al. (2011) · Genome Medicine · doi:10.1186/gm249 · Cited by 99 · see citing works

Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer’s disease

Dorey, E., Chang, N., Liu, Q. Y., Yang, Z., & Zhang, W. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1422-z · Cited by 99 · see citing works

Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C

Nowakowska, B., Obersztyn, E., Szymańska, K., Bekiesińska‐Figatowska, M., Xia, Z., Ricks, C. B., Bocian, E., Stockton, D. W., Szczałuba, K., Nawara, M., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31071 · Cited by 97 · see citing works

Genetic variation at CR1 increases risk of cerebral amyloid angiopathy

Biffi, A., Shulman, J. M., Jagiella, J. M., Cortellini, L., Ayres, A. M., Schwab, K. M., Brown, D. L., Silliman, S. L., Selim, M. H., Worrall, B. B., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182452b40 · Cited by 97 · see citing works

Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene

Ruiz, A., Heilmann, S., Becker, T., Hernández, I., Wagner, H., Thelen, M., Mauleón, A., Rosende-Roca, M., Bellenguez, C., Bis, J. C., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.2 · Cited by 97 · see citing works

Hippocampal atrophy rates and CSF biomarkers in elderly <i>APOE</i> 2 normal subjects

Chiang, G. C., Insel, P. S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S. T., Jack, C. R., Aisen, P. S., Petersen, R. C., Weiner, M. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ffe4d1 · Cited by 94 · see citing works

Genome-wide association reveals genetic effects on human Aβ 42 and τ protein levels in cerebrospinal fluids: a case control study

Han, M.-R., Schellenberg, G. D., Wang, L.-S., & Initiative, T. A. D. N. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-90 · Cited by 93 · see citing works

Kindlin-2 is required for myocyte elongation and is essential for myogenesis

Dowling, J. J., Vreede, A. P., Kim, S., Golden, J. A., & Feldman, E. L. (2008) · BMC Cell Biology · doi:10.1186/1471-2121-9-36 · Cited by 92 · see citing works

Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy

Jandus, C., Simon, H., & von Gunten, S. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.018 · Cited by 88 · see citing works

APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy

Breyhan, H., Wirths, O., Duan, K., Marcello, A., Rettig, J., & Bayer, T. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0539-7 · Cited by 87 · see citing works

A Pathogenic Presenilin-1 Deletion Causes Abberrant Aβ42 Production in the Absence of Congophilic Amyloid Plaques

Steiner, H., Révész, T., Neumann, M., Romig, H., Grim, M. G., Pesold, B., Kretzschmar, H. A., Hardy, J., Holton, J. L., Baumeister, R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007183200 · Cited by 86 · see citing works

Variant Alzheimer Disease With Spastic paraparesis: Neuropathological phenotype

Verkkoniemi, A., Kalimo, H., Paetau, A. E., Somer, M., Iwatsubo, T., Hardy, J., & Haltia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.5.483 · Cited by 85 · see citing works

Polygenic Analysis of Late-Onset Alzheimer’s Disease from Mainland China

Jiao, B., Liu, X., Zhou, L., Wang, M. H., Zhou, Y., Xiao, T., Zhang, W., Sun, R., Waye, M. M. Y., Tang, B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144898 · Cited by 82 · see citing works

A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum

Takao, M., Ghetti, B. F., Hayakawa, I., Ikeda, E., Fukuuchi, Y., Miravalle, L., Piccardo, P., Murrell, J. R., Glazier, B. S., & Koto, A. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0536-6 · Cited by 81 · see citing works

The integrin coactivator Kindlin-2 plays a critical role in angiogenesis in mice and zebrafish

Pluskota, E., Dowling, J. J., Gordon, N., Golden, J. A., Szpak, D., West, X. Z., Nestor, C., Ma, Y., Białkowska, K., Byzova, T. V., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321182 · Cited by 81 · see citing works

Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family

Yu, Y., Wu, J., Guan, L., Qi, L., Tang, Y., Ma, B., Zhan, J., Wang, Y., Fang, W., & Zhang, H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28151 · Cited by 81 · see citing works

Clues to CD2-associated Protein Involvement in Cytokinesis

Monzo, P., Gauthier, N. C., Keslair, F., Loubat, A., Field, C. M., MARCHAND‐BRUSTEL, Y. L., & Cormont, M. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-09-0773 · Cited by 80 · see citing works

Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer

Ramani, V. C., Hennings, L. J., & Haun, R. S. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-373 · Cited by 76 · see citing works

Expanding functions of lipoprotein receptors

Herz, J., Chen, Y., Masiulis, I., & Zhou, L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800077-jlr200 · Cited by 75 · see citing works

A novel Cas family member, HEPL, regulates FAK and cell spreading

Singh, M. K., Dadke, D., Nicolas, E., Serebriiskii, I. G., Apostolou, S., Canutescu, A., Egleston, B. L., & Golemis, E. A. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-09-0953 · Cited by 74 · see citing works

Late-onset Alzheimer disease risk variants mark brain regulatory loci

Allen, M., Kachadoorian, M., Carrasquillo, M. M., Karhade, A., Manly, L., Burgess, J. D., Wang, C., Serie, D., Wang, X., Siuda, J., et al. (2015) · Neurology Genetics · doi:10.1212/nxg.0000000000000012 · Cited by 73 · see citing works

Apolipoprotein E Genotype is Associated with Temporal and Hippocampal Atrophy Rates in Healthy Elderly Adults: A Tensor-Based Morphometry Study1

Lu, P. H., Thompson, P. M., Leow, A., Lee, G. J., Lee, A., Yanovsky, I., Parikshak, N., Khoo, T., Wu, S., Geschwind, D. H., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101398 · Cited by 70 · see citing works

GWAS Findings for Human Iris Patterns: Associations with Variants in Genes that Influence Normal Neuronal Pattern Development

Larsson, M., Duffy, D. L., Zhu, G., Liu, J. Z., MacGregor, S., McRae, A. F., Wright, M. J., Sturm, R. A., Mackey, D. A., Montgomery, G. W., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.07.011 · Cited by 69 · see citing works

AKAP9 Is a Genetic Modifier of Congenital Long-QT Syndrome Type 1

de Villiers, C. P., van der Merwe, L., Crotti, L., Goosen, A., George, A. L., Schwartz, P. J., Brink, P. A., Moolman‐Smook, J. C., & Corfield, V. A. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000580 · Cited by 67 · see citing works

Multiple loci influencing hippocampal degeneration identified by genome scan

Melville, S. A., Buros, J. L., Parrado, A., Vardarajan, B. N., Logue, M. W., Shen, L., Risacher, S. L., Kim, S., Jun, G., DeCarli, C. S., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23644 · Cited by 67 · see citing works

A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin

Deming, Y., Xia, J., Cai, Y., Lord, J., Holmans, P., Bertelsen, S., Holtzman, D., Morris, J. C., Bales, K., Pickering, E. H., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.009 · Cited by 66 · see citing works

Analyzing 54,936 Samples Supports the Association Between CD2AP rs9349407 Polymorphism and Alzheimer’s Disease Susceptibility

Chen, H., Wu, G., Jiang, Y., Feng, R., Liao, M., Zhang, L., Ma, G., Chen, Z., Zhao, B., Li, K., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8834-2 · Cited by 66 · see citing works

Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China

Jiao, B., Liu, X., Tang, B., Hou, L., Zhou, L., Zhang, F., Zhou, Y., Guo, J., Yan, X., & Shen, L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.025 · Cited by 66 · see citing works

Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease

Cuenco, K. T. (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1640 · Cited by 61 · see citing works

Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease

Morgen, K., Ramı́rez, A., Frölich, L., Tost, H., Plichta, M. M., Kölsch, H., Rakebrandt, F., Rienhoff, O., Jessen, F., Peters, O., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.11.001 · Cited by 59 · see citing works

Discovery and Development of Small Molecule SHIP Phosphatase Modulators

Viernes, D. R., Choi, L. B., Kerr, W. G., & Chisholm, J. D. (2013) · Medicinal Research Reviews · doi:10.1002/med.21305 · Cited by 57 · see citing works

Kindlins, Integrin Activation and the Regulation of Talin Recruitment to αIIbβ3

Kahner, B. N., Kato, H., Banno, A., Ginsberg, M. H., Shattil, S. J., & Ye, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034056 · Cited by 57 · see citing works

Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome

Kim, S. H., Fountoulakis, M., Cairns, N. J., & Lübec, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02035-1 · Cited by 56 · see citing works

The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer’s disease

Lee, J. H., Barral, S., & Reitz, C. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0060-8 · Cited by 56 · see citing works

Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model

Liao, F., Jiang, H., Srivatsan, S., Xiao, Q., Lefton, K. B., Yamada, K., Mahan, T. E., Lee, J.-M., Shaw, A. S., & Holtzman, D. M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0006-y · Cited by 53 · see citing works

Novel focal adhesion protein kindlin‐2 promotes the invasion of gastric cancer cells through phosphorylation of integrin β1 and β3

Shen, Z., Ye, Y., Kauttu, T., Seppänen, H. E., Vainionpää, S., Wang, S., Mustonen, H. K., & Puolakkainen, P. A. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23353 · Cited by 50 · see citing works

Opposite Role of Kindlin-1 and Kindlin-2 in Lung Cancers

Zhan, J., Zhu, X., Guo, Y., Wang, Y., Wang, Y., Qiang, G., Niu, M., Hu, J., Du, J., Li, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050313 · Cited by 50 · see citing works

A Role for Phospholipase D3 in Myotube Formation

Osisami, M., Ali, W. H., & Frohman, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033341 · Cited by 50 · see citing works

PLD3 is accumulated on neuritic plaques in Alzheimer’s disease brains

Satoh, J., Kino, Y., Yamamoto, Y., Kawana, N., Ishida, T., Saito, Y., & Arima, K. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0070-5 · Cited by 50 · see citing works

Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease

Beck, T. N., Nicolas, E., Kopp, M. C., & Golemis, E. A. (2014) · Oncoscience · doi:10.18632/oncoscience.64 · Cited by 50 · see citing works

Meta-analysis of the Association between Alzheimer Disease and Variants in GAB2, PICALM, and SORL1

Wang, Z., Lei, H., Zheng, M., Li, Y., Cui, Y., & Hao, F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9546-y · Cited by 49 · see citing works

Initial Assessment of the Pathogenic Mechanisms of the Recently Identified Alzheimer Risk Loci

Holton, P., Ryten, M., Nalls, M., Trabzuni, D., Weale, M. E., Hernandez, D., Crehan, H., Gibbs, J. R., Mayeux, R., Haines, J. L., et al. (2013) · Annals of Human Genetics · doi:10.1111/ahg.12000 · Cited by 48 · see citing works

Expression of MS4A and TMEM176 Genes in Human B Lymphocytes

Zuccolo, J., Deng, L., Unruh, T. L., Sanyal, R., Bau, J. A., Storek, J., Demetrick, D. J., Luider, J. M., Auer-Grzesiak, I. A., Mansoor, A., et al. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00195 · Cited by 48 · see citing works

Connecting the Dots: Potential of Data Integration to Identify Regulatory SNPs in Late-Onset Alzheimer's Disease GWAS Findings

Rosenthal, S. L., Barmada, M. M., Wang, X., Demirci, F. Y., & Kamboh, M. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095152 · Cited by 45 · see citing works

Uncovering γ-Secretase

Steiner, H. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332081 · Cited by 45 · see citing works

Genetic Analysis of 16 NMR‐Lipoprotein Fractions in Humans, the GOLDN Study

Kraja, A. T., Borecki, I. B., Tsai, M. Y., Ordovás, J. M., Hopkins, P. N., Lai, C., Wood, A. C., Straka, R. J., Hixson, J. E., Province, M. A., et al. (2012) · Lipids · doi:10.1007/s11745-012-3740-8 · Cited by 42 · see citing works

Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease

Liu, Y., Yu, J., Wang, H.-F., Hao, X., Yang, Y.-F., Jiang, T., Zhu, X., Cao, L., Zhang, D., & Tan, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114777 · Cited by 39 · see citing works

CR1 genotype is associated with entorhinal cortex volume in young healthy adults

Bralten, J., Franke, B., Vásquez, A. A., Heister, A. J. G. A. M., Brunner, H. G., Fernández, G., & Rijpkema, M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.017 · Cited by 39 · see citing works

CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques

Kok, E., Luoto, T. M., Haikonen, S., Goebeler, S., Haapasalo, H. K., & Karhunen, P. J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt71 · Cited by 35 · see citing works

RNA-binding protein CELF1 promotes tumor growth and alters gene expression in oral squamous cell carcinoma

House, R. P., Talwar, S., Hazard, E. S., Hill, E. G., & Palanisamy, V. (2015) · Oncotarget · doi:10.18632/oncotarget.6204 · Cited by 35 · see citing works

Alzheimer's Disease Neuroimaging Initiative. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease

Potkin, S. G., Guffanti, G., Lakatos, A., Ja, T., Kruggel, F., Jh, F., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., et al. (2009) · UNICA IRIS Institutional Research Information System (University of Cagliari) · Cited by 34 · see citing works

Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer Disease

Cai, G., Atzmon, G., Naj, A. C., Beecham, G. W., Barzilai, N., Haines, J. L., Sano, M., Pericak‐Vance, M. A., & Buxbaum, J. D. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.003 · Cited by 30 · see citing works

Alternative polyadenylation regulates CELF1/CUGBP1 target transcripts following T cell activation

Beisang, D. J., Reilly, C., & Bohjanen, P. R. (2014) · Gene · doi:10.1016/j.gene.2014.08.021 · Cited by 30 · see citing works

Effect of EPHA1 Genetic Variation on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts

Wang, H.-F., Initiative, A. D. N., Tan, L., Hao, X., Jiang, T., Tan, M., Liu, Y., Zhang, D., & Yu, J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141488 · Cited by 29 · see citing works

AKAP9, a Regulator of Microtubule Dynamics, Contributes to Blood-Testis Barrier Function

Venkatesh, D., Mruk, D. D., Herter, J. M., Culleré, X., Chojnacka, K., Cheng, C. Y., & Mayadas, T. N. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.10.007 · Cited by 29 · see citing works

CELF1 is Up-Regulated in Glioma and Promotes Glioma Cell Proliferation by Suppression of CDKN1B

Xia, L., Sun, C., Li, Q., Fěng, F., Qiao, E., Jiang, L., Wu, B., & Ge, M. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.11344 · Cited by 29 · see citing works

Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases

Ting, S. K. S., Chong, M.-S., Kandiah, N., Hameed, S., Tan, L., Au, W.-L., Prakash, K. M., Pavanni, R., Lee, T.-S., Foo, J.-N., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.012 · Cited by 26 · see citing works

Mutant Presenilin 2 Increases β-Secretase Activity Through Reactive Oxygen Species–Dependent Activation of Extracellular Signal–Regulated Kinase

Park, M. H., Choi, D. Y., Jin, H. W., Yoo, H. S., Han, J., Oh, K., Han, S., Hwang, D. Y., & Hong, J. T. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182432967 · Cited by 26 · see citing works

CR1 and the cell membrane proteins that bind C3 and C4

Wilson, J. G., Andriopoulos, N. A., & Fearon, D. T. (1987) · Immunologic Research · doi:10.1007/bf02918091 · Cited by 26 · see citing works

β‐Site amyloid precursor protein–cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin‐related receptor with A‐type repeats, soluble amyloid precursor protein, and tau

Tsolakidou, A. F., Alexopoulos, P., Guo, L., Grimmer, T., Westerteicher, C., Kratzer, M., Jiang, M., Bujo, H., Roselli, F., Leante, M. R., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.015 · Cited by 19 · see citing works

Association of single-nucleotide polymorphisms in RHOB and TXNDC3 with knee osteoarthritis susceptibility: two case-control studies in East Asian populations and a meta-analysis

Shi, D., Nakamura, T., Nakajima, M., Dai, J. M., Qin, J., Ni, H., Xu, Y., Chen, Y., Wei, J., Liu, B., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2423 · Cited by 18 · see citing works

Next Generation Sequencing in Alzheimer’s Disease

Bertram, L. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_17 · Cited by 17 · see citing works

SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease

Capsoni, S., Carlo, A.-S., Vignone, D., Amato, G., Criscuolo, C., Willnow, T. E., & Cattaneo, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121399 · Cited by 17 · see citing works

Mutations of desmoglein-2 in sudden death from arrhythmogenic right ventricular cardiomyopathy and sudden unexplained death

Zhang, M., Xue, A., Shen, Y., Oliveira, J. B., Li, L., Zhao, Z., & BURKE, A. P. (2015) · Forensic Science International · doi:10.1016/j.forsciint.2015.07.052 · Cited by 14 · see citing works

Divergent regulation of Pyk2/CAKβ phosphorylation by Ca2+ and cAMP in the hippocampus

Alier, K. A., & MORRIS, B. J. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.04.003 · Cited by 14 · see citing works

The APP A673T frequency differs between Nordic countries

Mengel‐From, J., Jeune, B., Pentti, T., McGue, M. K., Christensen, K., & Christiansen, L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.011 · Cited by 13 · see citing works

LRP2 in ependymal cells regulates BMP signaling in the adult neurogenic niche

Gajera, C. R., Emich, H., Lioubinski, O., Christ, A., Beckervordersandforth, R., Yoshikawa, K., Bachmann, S., Christensen, E., Götz, M., Kempermann, G., et al. (2010) · Development · doi:10.1242/dev.054361 · Cited by 8 · see citing works

F2–01–01: A rare variant alters UNC5C function and predisposes to Alzheimer's disease

Graham, R. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.04.125 · Cited by 5 · see citing works

A question of standards: What makes a good genetic association study?

Hattersley, A. T., & McCarthy, M. I. (2011) · Cited by 3 · see citing works

Alzheimer’s disease: risk factors and potentially protective measures

Silva, M. V. F., Loures, C. D. M. G., Alves, L. C. V., de Souza, L. C., Borges, K. B. G., & Ferriani, M. D. G. C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0524-y · Cited by 962 · see citing works

Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease

Kesika, P., Suganthy, N., Sivamaruthi, B. S., & Chaiyasut, C. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118627 · Cited by 479 · see citing works

Lipids and Alzheimer’s Disease

Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485 · see citing works

New Insights Into the Pathogenesis of Alzheimer's Disease

Fan, L., Mao, C.-Y., Hu, X., Zhang, S., Yang, Z.-H., Hu, Z., Sun, H.-F., Fan, Y., Dong, Y., Yang, J., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2019.01312 · Cited by 294 · see citing works

Cellular Specificity of NF-κB Function in the Nervous System

Dresselhaus, E. C., & Meffert, M. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01043 · Cited by 345 · see citing works

A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ

Kwart, D., Gregg, A., Scheckel, C., Murphy, E. A., Paquet, D., Duffield, M. D., Fak, J. J., Olsen, O., Darnell, R. B., & Tessier‐Lavigne, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.010 · Cited by 317 · see citing works

In vitro Models of Neurodegenerative Diseases

Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00328 · Cited by 293 · see citing works

Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes

Zuroff, L. R., Daley, D. A., Black, K. L., & Koronyo‐Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275 · see citing works

Alzheimer’s Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence

Gosztyla, M. L., Brothers, H. M., & Robinson, S. R. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171133 · Cited by 238 · see citing works

Early diagnosis of Alzheimer’s disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts

Rossini, P. M., Iorio, R. D., Vecchio, F., Anfossi, M., Babiloni, C., Bozzali, M., Bruni, A. C., Cappa, S. F., Escudero, J., Fraga, F. J., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.03.003 · Cited by 239 · see citing works

Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease

Morris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212 · see citing works

Alzheimer's disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges

Safiri, S., Jolfayi, A. G., Fazlollahi, A., Morsali, S., Sarkesh, A., Sorkhabi, A. D., Golabi, B., Aletaha, R., Asghari, K. M., Hamidi, S., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1474043 · Cited by 242 · see citing works

Neuroinflammation: A Potential Risk for Dementia

Ahmad, M. A., Kareem, O., Khushtar, M., Akbar, M., Haque, M. R., Iqubal, A., Haider, M. F., Pottoo, F. H., Abdulla, F. S., Al-Haidar, M. B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020616 · Cited by 163 · see citing works

Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease

Pennisi, M., Crupi, R., Di Paola, R., Ontario, M. L., Bella, R., Calabrese, E. J., Crea, R., Cuzzocrea, S., & Calabrese, V. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23986 · Cited by 157 · see citing works

Melatonin: A review of its potential functions and effects on neurological diseases

Günata, M., Parlakpınar, H., & Acet, A. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.025 · Cited by 154 · see citing works

Neurodegeneration and the Circadian Clock

Hood, S., & Amir, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00170 · Cited by 150 · see citing works

Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs

Tewari, D., Stankiewicz, A. M., Mocan, A., Sah, A. N., Tzvetkov, N. T., Huminiecki, Ł., Horbańczuk, J. O., & Atanasov, A. G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00003 · Cited by 136 · see citing works

β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View

Penke, B., Bogár, F., & Fülöp, L. (2017) · Molecules · doi:10.3390/molecules22101692 · Cited by 135 · see citing works

Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation

Gamage, R. V., Wagnon, I. M., Rossetti, I., Childs, R., Niedermayer, G., Chesworth, R., & Gyengési, E. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.577912 · Cited by 133 · see citing works

Alzheimer's disease in the omics era

Sancesario, G. M., & Bernardini, S. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.06.011 · Cited by 111 · see citing works

Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels

Robert, J., Button, E. B., Yuen, B., Gilmour, M., Kang, K., Bahrabadi, A., Stukas, S. K., Zhao, W., Kulić, I., & Wellington, C. L. (2017) · eLife · doi:10.7554/elife.29595 · Cited by 113 · see citing works

Role of miRNAs in Alzheimer’s Disease and Possible Fields of Application

Silvestro, S., Bramanti, P., & Mazzon, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163979 · Cited by 112 · see citing works

MicroRNA expression in extracellular vesicles as a novel blood‐based biomarker for Alzheimer's disease

Kumar, A., Su, Y., Sharma, M., Singh, S., Kim, S., Peavey, J. J., Suerken, C. K., Lockhart, S. N., Whitlow, C. T., Craft, S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13055 · Cited by 110 · see citing works

Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants

Hoogmartens, J., Cacace, R., & Broeckhoven, C. V. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12155 · Cited by 101 · see citing works

Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease

López‐Ortiz, S., Pinto-Fraga, J., Valenzuela, P. L., Martín-Hernández, J., Seisdedos, M. M., Garcı́a, Ó., Toschi, N., Giuliano, F. D., Garaci, F. G., Mercuri, N. B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062897 · Cited by 101 · see citing works

Golgi Fragmentation in Neurodegenerative Diseases: Is There a Common Cause?

Martínez‐Menárguez, J. A., Tomás, M., Martínez-Martínez, N., & Martínez‐Alonso, E. (2019) · Cells · doi:10.3390/cells8070748 · Cited by 95 · see citing works

A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy

Taylor, X., Cisternas, P., You, Y., You, Y., Xiang, S., Marambio, Y. G., Zhang, J., Vidal, R., & Lasagna‐Reeves, C. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01900-7 · Cited by 91 · see citing works

Sustainable method for Alzheimer dementia prediction in mild cognitive impairment: Electroencephalographic connectivity and graph theory combined with apolipoprotein E

Vecchio, F., Miraglia, F., Iberite, F., Lacidogna, G., Guglielmi, V., Marra, C., Pasqualetti, P., Tiziano, F. D., & Rossini, P. M. (2018) · Annals of Neurology · doi:10.1002/ana.25289 · Cited by 89 · see citing works

Essential Oils as Treatment Strategy for Alzheimerʼs Disease: Current and Future Perspectives

Benny, A., & Thomas, J. (2018) · Planta Medica · doi:10.1055/a-0758-0188 · Cited by 89 · see citing works

Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer’s disease

Kim, D. K., Han, D., Park, J., Choi, H., Park, J., Cha, M.-Y., Woo, J. J., Byun, M. S., Lee, D. Y., Kim, Y., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0326-z · Cited by 86 · see citing works

Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer’s Disease

Ali, F. R., & Siddique, Y. H. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666190319141835 · Cited by 82 · see citing works

An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease

Ratan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V. K., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 87 · see citing works

Alzheimer’s Disease: Pathogenesis and Therapeutic Interventions

Ogbodo, J. O., Agbo, C. P., Njoku, U. O., Ogugofor, M. O., Egba, S. I., Ihim, S. A., Echezona, A. C., Brendan, K. C., Upaganlawar, A. B., & Upasani, C. D. (2021) · Current Aging Science · doi:10.2174/1874609814666210302085232 · Cited by 81 · see citing works

The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk

Fan, J., Tao, W., Li, X., Li, H., Zhang, J., Wei, D., Chen, Y., & Zhang, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051177 · Cited by 83 · see citing works

An overview of the genes and biomarkers in Alzheimer’s disease

Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Wang, T., Bei, K., Changalath, C., & Rajasekaran, J. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102599 · Cited by 85 · see citing works

Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype

Friedberg, J. S., Aytan, N., Cherry, J. D., Xia, W., Standring, O. J., Alvarez, V. E., Nicks, R., Svirsky, S. E., Meng, G., Jun, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59869-5 · Cited by 78 · see citing works

Studies for Improving a Rat Model of Alzheimer’s Disease: Icv Administration of Well-Characterized β-Amyloid 1-42 Oligomers Induce Dysfunction in Spatial Memory

Kasza, Á., Penke, B., Frank, Z., Bozsó, Z., Szegedi, V., Hunya, Á. G., Németh, K., Kozma, G., & Fülöp, L. (2017) · Molecules · doi:10.3390/molecules22112007 · Cited by 75 · see citing works

Transcriptomics in Alzheimer’s Disease: Aspects and Challenges

Bagyinszky, E., Giau, V. V., & An, S. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103517 · Cited by 75 · see citing works

The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review

Freudenberg‐Hua, Y., Li, W., & Davies, P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00108 · Cited by 74 · see citing works

Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation

Aaseth, J., Alexander, J., Bjørklund, G., Hestad, K. A., Dušek, P., Roos, P. M., & Alehagen, U. (2016) · BioMetals · doi:10.1007/s10534-016-9959-8 · Cited by 73 · see citing works

Extracellular vesicles – propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases

Vassileff, N., Cheng, L., & Hill, A. F. (2020) · Journal of Cell Science · doi:10.1242/jcs.243139 · Cited by 73 · see citing works

The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease

Chachaj, A., Gąsiorowski, K., Szuba, A., Sieradzki, A., & Leszek, J. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411091332 · Cited by 71 · see citing works

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics

Esposito, M. M., & Sherr, G. L. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00476 · Cited by 67 · see citing works

Quantile regression for functional partially linear model in ultra-high dimensions

Ma, H., Li, T., Hongtu Zhu, B., & Zhu, Z. (2018) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2018.06.005 · Cited by 63 · see citing works

Effects of Anserine/Carnosine Supplementation on Mild Cognitive Impairment with APOE4

Masuoka, N., Yoshimine, C., Hori, M., Tanaka, M., Asada, T., Abe, K., & Hisatsune, T. (2019) · Nutrients · doi:10.3390/nu11071626 · Cited by 63 · see citing works

Sialometabolism in Brain Health and Alzheimer’s Disease

Rawal, P., & Zhao, L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.648617 · Cited by 62 · see citing works

Recent Progress in the Pharmacotherapy of Alzheimer’s Disease

Khoury, R., Patel, K., Gold, J., Hinds, S., & Grossberg, G. T. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0499-x · Cited by 62 · see citing works

MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities

AbuelEzz, N. Z., Nasr, F. E., Abdulkader, M. A., Bassiouny, A. R., & Zaky, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.743573 · Cited by 60 · see citing works

High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice

Gao, H., Zhang, A., Yu, J., Sun, H. J., Kong, L. D., Wang, X., Yan, G., Liu, L., & Wang, X. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.06.032 · Cited by 56 · see citing works

<i>INPP5D</i> deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease

Lin, P. B., Tsai, A. P., Soni, D., Lee‐Gosselin, A., Moutinho, M., Puntambekar, S. S., Landreth, G. E., Lamb, B. T., & Oblak, A. L. (2023) · Alzheimer's &amp; Dementia · doi:10.1002/alz.12849 · Cited by 54 · see citing works

Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events

Asik, R. M., Suganthy, N., Aarifa, M. A., Kumar, A., Szigeti, K., Máthé, D., Gulyás, B. Z., Archunan, G., & Padmanabhan, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091126 · Cited by 53 · see citing works

Machine learning based multimodal neuroimaging genomics dementia score for predicting future conversion to alzheimer’s disease

Mirabnahrazam, G., Initiative, T. A. D. N., Ma, D., Lee, S., Popuri, K., Lee, H., Cao, J., Wang, L., Galvin, J. E., & Beg, M. F. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220021 · Cited by 50 · see citing works

Neurophysiological Hallmarks of Neurodegenerative Cognitive Decline: The Study of Brain Connectivity as A Biomarker of Early Dementia

Rossini, P. M., Miraglia, F., Alù, F., Cotelli, M., Ferreri, F., Iorio, R. D., Iodice, F., & Vecchio, F. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020034 · Cited by 49 · see citing works

Genetic Data: Potential Uses and Misuses in Marketing

Daviet, R., Nave, G., & Wind, J. Y. (2020) · Journal of Marketing · doi:10.1177/0022242920980767 · Cited by 52 · see citing works

Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease

Cummings, J. L., Ortiz, A. A., Castellino, J., & Kinney, J. W. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15619 · Cited by 50 · see citing works

APOE4 genotype exacerbates the impact of menopause on cognition and synaptic plasticity in APOE‐TR mice

Pontifex, M. G., Martinsen, A., Saleh, R. N. M., Harden, G., Tejera, N., Müller, M. M., Fox, C., Vauzour, D., & Minihane, A. M. (2021) · The FASEB Journal · doi:10.1096/fj.202002621rr · Cited by 48 · see citing works

Aromatherapy for the brain: Lavender's healing effect on epilepsy, depression, anxiety, migraine, and Alzheimer's disease: A review article

Bavarsad, N. H., Bagheri, S., Kourosh‐Arami, M., & Komaki‬, A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18492 · Cited by 48 · see citing works

Pseudoexfoliation and Alzheimer’s associated CLU risk variant, rs2279590, lies within an enhancer element and regulates CLU, EPHX2 and PTK2B gene expression

Padhy, B., Hayat, B., Nanda, G. G., Mohanty, P. P., & Alone, D. P. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx329 · Cited by 48 · see citing works

Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer’s Disease

Cerasuolo, M., Di Meo, I., Auriemma, M. C., Paolisso, G., Papa, M., & Rizzo, M. R. (2024) · Biomolecules · doi:10.3390/biom14111362 · Cited by 47 · see citing works

Polygenic risk score in postmortem diagnosed sporadic early-onset Alzheimer's disease

Chaudhury, S., Patel, T., Barber, I., Guetta‐Baranes, T., Brookes, K. J., Chappell, S., Turton, J. C., Guerreiro, R. J., Brás, J., Hernandez, D. G., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.035 · Cited by 47 · see citing works

CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics

Sen, T., & Thummer, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00564-w · Cited by 50 · see citing works

Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go

Prasanna, P., & Upadhyay, A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00224 · Cited by 46 · see citing works

Systems healthcare: a holistic paradigm for tomorrow

Fiandaca, M. S., Mapstone, M. E., Connors, E. E., Jacobson, M., Monuki, E. S., Malik, S., Macciardi, F. M., & Federoff, H. J. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0521-2 · Cited by 45 · see citing works

Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer’s disease

Pons, V., Lévesque, P., Plante, M.-M., & Rivest, S. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00747-7 · Cited by 43 · see citing works

Pathogenesis of Neurodegenerative Diseases and the Protective Role of Natural Bioactive Components

Samanta, S., Chakraborty, S., & Bagchi, D. (2023) · Journal of the American Nutrition Association · doi:10.1080/27697061.2023.2203235 · Cited by 43 · see citing works

siRNA drug delivery across the blood–brain barrier in Alzheimer's disease

Sajid, M. I., Sheikh, F. S., Anis, F., Nasim, N., Sumbria, R. K., Nauli, S. M., & Tiwari, R. K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114968 · Cited by 45 · see citing works

Anserine/Carnosine Supplementation Preserves Blood Flow in the Prefrontal Brain of Elderly People Carrying APOE e4

Ding, Q., Tanigawa, K., Kaneko, J., Totsuka, M., Katakura, Y., Imabayashi, E., Matsuda, H., & Hisatsune, T. (2018) · Aging and Disease · doi:10.14336/ad.2017.0809 · Cited by 43 · see citing works

Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia

Alzobaidi, N., Quasimi, H., Emad, N. A., Alhalmi, A., & Naqvi, M. (2021) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s299589 · Cited by 43 · see citing works

Regulation of the Late Onset alzheimer’s Disease Associated HLA-DQA1/DRB1 Expression

Zhang, X., Zou, M., Wu, Y., Jiang, D., Wu, T., Zhao, Y., Wu, D., Cui, J., & Li, G. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221085066 · Cited by 45 · see citing works

Pathophysiological Ionotropic Glutamate Signalling in Neuroinflammatory Disease as a Therapeutic Target

Fairless, R., Bading, H., & Diem, R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.741280 · Cited by 42 · see citing works

The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy

Cisternas, P., Taylor, X., & Lasagna‐Reeves, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246319 · Cited by 41 · see citing works

Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches

Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042320 · Cited by 43 · see citing works

A comprehensive interpretable machine learning framework for mild cognitive impairment and Alzheimer’s disease diagnosis

Vlontzou, M. E., Αθανασίου, Μ., Dalakleidi, K. V., Skampardoni, I., Davatzikos, C. A., & Nikita, K. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-92577-6 · Cited by 42 · see citing works

The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s

Prasanth, M. I., Malar, D. S., Tencomnao, T., & Brimson, J. M. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1939681 · Cited by 40 · see citing works

Factors Associated with Alzheimer's Disease: An Overview of Reviews

Rochoy, M., Rivas, V., Chazard, E., Decarpentry, E., Saudemont, G., Hazard, P.-A., Puisieux, F. L., Gautier, S., & Bordet, R. (2019) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2019.7 · Cited by 37 · see citing works

Amyloid β induces interneuron-specific changes in the hippocampus of APPNL-F mice

Sos, K. E., Mayer, M. I., Takács, V. T., Major, A., Bardóczi, Z., Beres, B. M., Szeles, T., Saito, T., Saido, T. C., Mody, I., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233700 · Cited by 37 · see citing works

The dialog between neurons and microglia in Alzheimer's disease: The neurotransmitters view

Stolero, N., & Frenkel, D. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15262 · Cited by 37 · see citing works

Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease

Almansoub, H. A. M. M., Tang, H. R., Wu, Y., Wang, D., Mahaman, Y. A. R., Wei, N., Almansob, Y. A. M., He, W., & Liu, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180868 · Cited by 37 · see citing works

Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?

Silvestro, S., Valeri, A., & Mazzon, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042011 · Cited by 35 · see citing works

Revealing the potential therapeutic mechanism of Lonicerae Japonicae Flos in Alzheimer’s disease: a computational biology approach

Qin, X., Xiang, Y., Liu, Y., Chen, Y., He, Q., Chen, T., Tang, L., He, B., & Li, J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1468561 · Cited by 35 · see citing works

Bridging Genomics to Phenomics at Atomic Resolution through Variation Spatial Profiling

Wang, C., & Balch, W. E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.059 · Cited by 35 · see citing works

The vexing complexity of the amyloidogenic pathway

Castro, M., Hadziselimovic, A., & Sanders, C. R. (2019) · Protein Science · doi:10.1002/pro.3606 · Cited by 36 · see citing works

Serum and CSF metabolomics analysis shows Mediterranean Ketogenic Diet mitigates risk factors of Alzheimer’s disease

Schweickart, A., Batra, R., Neth, B. J., Martino, C., Shenhav, L., Zhang, A. R., Shi, P., Karu, N., Huynh, K., Meikle, P. J., et al. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00016-3 · Cited by 36 · see citing works

Alterations of Golgi organization in Alzheimer’s disease: A cause or a consequence?

Ayala, I., & Colanzi, A. (2016) · Tissue and Cell · doi:10.1016/j.tice.2016.11.007 · Cited by 34 · see citing works

Genetic Variants and Oxidative Stress in Alzheimer’s Disease

Kowalska, M., Wize, K., Prendecki, M., Lianeri, M., Kozubski, W. P., & Dorszewska, J. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200224121447 · Cited by 34 · see citing works

γ-secretase promotes Drosophila postsynaptic development through the cleavage of a Wnt receptor

Restrepo, L. J., DePew, A. T., Moese, E. R., Tymanskyj, S. R., Parisi, M. J., Aimino, M. A., Duhart, J. C., Fei, H., & Mosca, T. J. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.05.006 · Cited by 26 · see citing works

Alzheimer’s Disease (AD) Therapeutics—2: Beyond Amyloid—Re-Defining AD and Its Causality to Discover Effective Therapeutics

Mullane, K., & Williams, M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.027 · Cited by 32 · see citing works

Early diagnosis and targeted treatment strategy for improved therapeutic outcomes in Alzheimer’s disease

Guest, F. L., Rahmoune, H., & Guest, P. C. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-42667-5_8 · Cited by 34 · see citing works

Effects of Ginsenoside Rg1 on Learning and Memory in a Reward‐directed Instrumental Conditioning Task in Chronic Restraint Stressed Rats

Kezhu, W., Xu, P., Lü, C., Liming, D., Beiyue, Z., Jingwei, L., Yanyan, Y., & Liu, X. (2016) · Phytotherapy Research · doi:10.1002/ptr.5733 · Cited by 32 · see citing works

Superparamagnetic nanoparticle‐enhanced MRI of Alzheimer's disease plaques and activated microglia in 3X transgenic mouse brains: Contrast optimization

Tafoya, M., Madi, S., & Sillerud, L. O. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25563 · Cited by 31 · see citing works

Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: Present and future applications

Reale, M., Gonzales-Portillo, I., & Borlongan, C. V. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146535 · Cited by 31 · see citing works

A concise review of human brain methylome during aging and neurodegenerative diseases

Prasad G, R., & Jho, E.-H. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.10.215 · Cited by 31 · see citing works

Pregnancy as a model for aging

Giller, A., Andrawus, M., Gutman, D., & Atzmon, G. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101093 · Cited by 30 · see citing works

Interaction between genetic factors, Porphyromonas gingivalis and microglia to promote Alzheimer’s disease

Olsen, I., & Singhrao, S. K. (2020) · Journal of Oral Microbiology · doi:10.1080/20002297.2020.1820834 · Cited by 32 · see citing works

Molecular Pathogenesis and Interventional Strategies for Alzheimer’s Disease: Promises and Pitfalls

Bhute, S., Sarmah, D., Datta, A., Rane, P., Shard, A., Goswami, A., Borah, A., Kalia, K., Dave, K. R., & Bhattacharya, P. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00104 · Cited by 30 · see citing works

Osteoporosis and Alzheimer´s disease (or Alzheimer´s disease and Osteoporosis)

Wanionok, N. E., Morel, G. R., & Fernández, J. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102408 · Cited by 30 · see citing works

CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects

Khan, M. S., Qureshi, N., Khan, R., Son, Y., & Maqbool, T. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1578138 · Cited by 33 · see citing works

POLG R964C and GBA L444P mutations in familial Parkinson's disease: Case report and literature review

Hsieh, P., Wang, C., Tsai, C., Yeh, Y., Lee, Y. S., & Wu, Y. (2019) · Brain and Behavior · doi:10.1002/brb3.1281 · Cited by 29 · see citing works

GSK3‐ARC/Arg3.1 and GSK3‐Wnt signaling axes trigger amyloid‐β accumulation and neuroinflammation in middle‐aged Shugoshin 1 mice

Rao, C. V., Farooqui, M., Madhavaram, A., Zhang, Y., Asch, A. S., & Yamada, H. Y. (2020) · Aging Cell · doi:10.1111/acel.13221 · Cited by 29 · see citing works

Role of non‑coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review)

Pierouli, K., Papakonstantinou, E., Papageorgiou, L., Diakou, I., Mitsis, Τ., Dragoumani, K., Spandidos, D. A., Bacopoulou, F., Chrousos, G. P., Goulielmos, G. N., et al. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5208 · Cited by 29 · see citing works

The genetic landscape of Alzheimer disease

Carmona, S., Hardy, J., & Guerreiro, R. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00026-0 · Cited by 133 · see citing works

The Genetic Basis of Alzheimer’s Disease

Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00002-2 · Cited by 6 · see citing works

Genetics of Alzheimer’s Disease

Chouraki, V. A., & Seshadri, S. S. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800149-3.00005-6 · Cited by 208 · see citing works

The Genetics of Alzheimer’s Disease

Tanzi, R. E. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199934959.003.0060 · Cited by 19 · see citing works

The Genetics of Alzheimer Disease: Back to the Future

Bertram, L., Lill, C. M., & Tanzi, R. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.013 · Cited by 834 · see citing works